Module

Non−AIDS-Defining Cancers in the Era of HAART

Source: HIV/AIDS Annual Update 2008

Non−AIDS-Defining Cancers in the Era of HAART

Faculty:
Alexandra M. Levine, MD

CME CREDIT INFORMATION

Release Date: 05/22/08

Expiration Date: 05/21/09

Physicians: maximum of 1.0 AMA PRA Category 1 Credit(s)™

Pharmacists: 1.1 contact hours (0.11 CEUs)

Registered Nurses: 1.1 Nursing CE credits

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Describe the epidemiology and characteristics of lung cancer among HIV-infected patients
Discuss the role of human papillomavirus in the etiology of anal and head and neck cancers
Summarize the epidemiology, clinical characteristics, and treatment of Hodgkin’s disease among HIV-infected people

Topics covered include:

Introduction
Lung Cancer: Epidemiology
Lung Cancer: Clinical Characteristics
Survival in HIV-Infected People With Lung Cancer
Screening for and Prevention of Lung-Cancer in HIV-Infected Patients
HPV-Based Cancers: Overview
Anal Cancer: Epidemiology
Anal Dysplasia
Anal Precursor Lesions
Invasive Anal Cancer
HPV-Related Head and Neck Cancers
Hodgkin’s Lymphoma (Hodgkin’s Disease)
Summary: Implications for Clinical Practice

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.